Your Location:
Home >
Browse articles >
Clinical Researches on Chinese Patent Drug for Diabetes: A Scoping Review
Clinical Researches on Chinese Patent Drug for Diabetes: A Scoping Review
Enhanced Publication- Chinese Journal of Experimental Traditional Medical Formulae Vol. 29, Issue 6, Pages: 176-184(2023)
DOI: 10.13422/j.cnki.syfjx.20230691
Scan QR Code
Full Text(HTML)
Figs( 1 ) Tabs( 6 )
References
Publication Info
Metrics
312
Views
853
Downloads
2
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Oral Chinese Patent Mediciens for Lung Cancer:A Scoping Review of Clinical Evidence
A Multicenter, Double-blind,Randomized Controlled Study of Qingfei Huatan Tongqiao Formula for Treating Adenoid Hypertrophy in Children
Regulatory Mechanisms and Strategies of Traditional Chinese Medicine Intervention in Diabetic Atherosclerosis Based on Macrophage Autophagy: A Review
Mechanisms of Jiangtang No. 3 Prescription in Alleviating Adipose Tissue Insulin Resistance in Diabetic Rats via TLR4/NF-κB/NLRP3 Signaling Pathway-mediated Inflammation
Classic Traditional Chinese Medicine Prescriptions in Treatment of Cancer-related Anemia: A Review
Related Author
WANG Juan
HAN Xu
JIANG Miao
GUO Hong-tao
GU Hao
LIAO Xing
LIU Anqi
JIANG Zhiyan
Related Institution
Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences
The First Affiliated Hospital of Henan University of Chinese Medicine
Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
The First Clinical Medical College of Henan University of Chinese Medicine
Qi-Huang Chinese Medicine School, Beijing University of Chinese Medicine


